$2.32T
Total marketcap
$108.19B
Total volume
BTC 50.00%     ETH 15.45%
Dominance

Agilent Technologies, Inc. A1GI34.SA Stock

328.4 BRL {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Brazil
Exchange
São Paulo
Market Cap
210.06B BRL
LOW - HIGH [24H]
328.4 - 328.4 BRL
VOLUME [24H]
0 BRL
{{ volume }}
P/E Ratio
30.86
Earnings per share
10.64 BRL

Agilent Technologies, Inc. Price Chart

Agilent Technologies, Inc. A1GI34.SA Financial and Trading Overview

Agilent Technologies, Inc. stock price 328.4 BRL
Previous Close 291.36 BRL
Open 0 BRL
Bid 290.86 BRL x N/A
Ask 295.83 BRL x N/A
Day's Range 0 - 0 BRL
52 Week Range 0 - 408.36 BRL
Volume 0 BRL
Avg. Volume 0 BRL
Market Cap 174.44B BRL
Beta (5Y Monthly) 1.044014
PE Ratio (TTM) 26.804047
EPS (TTM) 10.64 BRL
Forward Dividend & Yield 2.25 (0.77%)
Ex-Dividend Date January 2, 2023
1y Target Est N/A

A1GI34.SA Valuation Measures

Enterprise Value 173.84B BRL
Trailing P/E 26.804047
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 24.77818
Price/Book (mrq) 29.762499
Enterprise Value/Revenue 24.693
Enterprise Value/EBITDA 84.428

Trading Information

Agilent Technologies, Inc. Stock Price History

Beta (5Y Monthly) 1.044014
52-Week Change -1.099%
S&P500 52-Week Change 20.43%
52 Week High 408.36 BRL
52 Week Low 0 BRL
50-Day Moving Average 368.8 BRL
200-Day Moving Average 374.18 BRL

A1GI34.SA Share Statistics

Avg. Volume (3 month) 0 BRL
Avg. Daily Volume (10-Days) 2 BRL
Shares Outstanding 590.75M
Float 588.84M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.87
Trailing Annual Dividend Yield 0.29%
5 Year Average Dividend Yield N/A
Payout Ratio 0.1418
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends October 31, 2022
Most Recent Quarter (mrq) April 30, 2023
Next Fiscal Year End October 31, 2023

Profitability

Profit Margin 19.18%
Operating Margin (ttm) 25.11%
Gross Margin 54.58%
EBITDA Margin 29.24%

Management Effectiveness

Return on Assets (ttm) 10.40%
Return on Equity (ttm) 24.78%

Income Statement

Revenue (ttm) 7.04B BRL
Revenue Per Share (ttm) 11.85 BRL
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 3.72B BRL
EBITDA 2.06B BRL
Net Income Avi to Common (ttm) 1.35B BRL
Diluted EPS (ttm) 10.87
Quarterly Earnings Growth (yoy) 10.19%

Balance Sheet

Total Cash (mrq) 1.18B BRL
Total Cash Per Share (mrq) 1.99 BRL
Total Debt (mrq) 2.89B BRL
Total Debt/Equity (mrq) 50.01 BRL
Current Ratio (mrq) 2.37
Book Value Per Share (mrq) 9.7895

Cash Flow Statement

Operating Cash Flow (ttm) 1.47B BRL
Levered Free Cash Flow (ttm) 867.12M BRL

Profile of Agilent Technologies, Inc.

Country Brazil
State CA
City Santa Clara
Address 5301 Stevens Creek Boulevard
ZIP 95051
Phone 800 227 9770
Website https://www.agilent.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 18400

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Q&A For Agilent Technologies, Inc. Stock

What is a current A1GI34.SA stock price?

Agilent Technologies, Inc. A1GI34.SA stock price today per share is 328.4 BRL.

How to purchase Agilent Technologies, Inc. stock?

You can buy A1GI34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Agilent Technologies, Inc.?

The stock symbol or ticker of Agilent Technologies, Inc. is A1GI34.SA.

Which industry does the Agilent Technologies, Inc. company belong to?

The Agilent Technologies, Inc. industry is Diagnostics & Research.

How many shares does Agilent Technologies, Inc. have in circulation?

The max supply of Agilent Technologies, Inc. shares is 639.65M.

What is Agilent Technologies, Inc. Price to Earnings Ratio (PE Ratio)?

Agilent Technologies, Inc. PE Ratio is 30.86466000 now.

What was Agilent Technologies, Inc. earnings per share over the trailing 12 months (TTM)?

Agilent Technologies, Inc. EPS is 10.64 BRL over the trailing 12 months.

Which sector does the Agilent Technologies, Inc. company belong to?

The Agilent Technologies, Inc. sector is Healthcare.